| Latest Decode Genetics News Headlines |
| Date | Time | Source | |
| 11/24/2009 | 3:30PM | PRNUS | deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal
REYKJAVIK, Iceland, November 24 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (NASDAQ:DCGN) today announced that it has received notice from the Nasdaq Stock Market that trading in the company's common stock will be suspended as of November 30, 2009 and a Form 25-NSE will be filed with the Securities and Exchange... More...>> |
| 11/24/2009 | 9:36AM | PRNUS | deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court
Iceland-Based Subsidiary to Use Debtor-in-Possession Financing to Continue Genetics Operations and Offer All Product and Service Lines During Chapter 11 Process
REYKJAVIK, Iceland, November 24 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (NASDAQ:DCGN) today announced the approval of all of its "first day" motions... More...>> |
| 11/17/2009 | 2:48AM | PRNUS | deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets
Enters into asset purchase agreement and receives commitment for debtor-in-possession financing to continue operations during Chapter 11 process
REYKJAVIK, Iceland, Nov. 17 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (NASDAQ:DCGN) today announced that it has filed a voluntary petition for relief under Chapter 11... More...>> |
| 09/17/2009 | 4:12PM | PRNUS | deCODE Receives Nasdaq Bid Price Deficiency Notice
REYKJAVIK, Iceland, September 17 /PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ:DCGN) today announced that it has received a notice from the Nasdaq Stock Market indicating that deCODE is not in compliance with Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Rule") because the closing bid price per share for... More...>> |
| 07/13/2009 | 1:20PM | PRNUS | deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke
Will be Integrated Into deCODE AF(TM) DNA-based Risk Assessment Test, and Into the deCODEme(TM) and deCODEme Cardio(TM) Scans
REYKJAVIK, Iceland, July 13 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (NASDAQ:DCGN) and colleagues from Europe and the United States today report the discovery of a common single-letter... More...>> |
| 07/01/2009 | 1:20PM | PRNUS | deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia
Findings Expand Knowledge of the Biology of the Disease and Provide Potential New Drug Targets
REYKJAVIK, Iceland, July 1 /PRNewswire-FirstCall/ -- The largest study of the genetics of schizophrenia ever undertaken has revealed several new common single-letter variants in the sequence of the human genome (SNPs) linked... More...>> |
| 07/01/2009 | 1:20PM | PRNUS | deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia
Findings Expand Knowledge of the Biology of the Disease and Provide Potential New Drug Targets
REYKJAVIK, Iceland, July 1 /PRNewswire-FirstCall/ -- The largest study of the genetics of schizophrenia ever undertaken has revealed several new common single-letter variants in the sequence of the human genome (SNPs) linked... More...>> |
| 06/29/2009 | 8:14AM | PRNUS | deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
Findings Offer Promising Target for Drugs to Better Regulate Calcium Metabolism, Are Integrated Into deCODEme(TM)
REYKJAVIK, Iceland, June 29 /PRNewswire-FirstCall/ -- A discovery by scientists at deCODE genetics (NASDAQ:DCGN) and academic colleagues from Iceland, the Netherlands and Denmark has pointed to a common... More...>> |
| 05/20/2009 | 10:25AM | PRNUS | deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation
Underscores Quality of deCODE's Laboratory and Tests, Fulfilling Key Federal and State Certification Requirements and Broadening Marketing Channels
REYKJAVIK, Iceland, May 20 /PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ:DCGN) today announced that its CLIA-registered DNA isolation and genotyping laboratory, which... More...>> |
| 05/17/2009 | 2:24PM | PRNUS | deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease
Reykjavik, ICELAND, May 17 /PRNewswire-FirstCall/ -- In a paper published today in the online edition of Nature Genetics, scientists from deCODE genetics (NASDAQ:DCGN) and academic colleagues from Iceland, Denmark and the Netherlands present the discovery of single letter variations in the sequence of the human genome... More...>> |
| 05/11/2009 | 4:20PM | PRNUS | deCODE genetics Announces First Quarter 2009 Financial Results
REYKJAVIK, Iceland, May 11 /PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ:DCGN) today announced its consolidated financial results for the quarter ended March 31, 2009. A conference call to discuss these results and recent developments in the company's business will be webcast live tomorrow, Tuesday, May 12, at 8:00am... More...>> |
| 05/07/2009 | 8:32AM | PRNUS | deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results
REYKJAVIK, Iceland, May 7 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (NASDAQ:DCGN) today announced that it will report its first quarter 2009 financial results in a press release to be issued on Monday, May 11, after the close of the market in New York. The company will host a live webcast of its conference call... More...>> |
| 04/28/2009 | 9:26PM | PRNUS | Nasdaq Stays Suspension of Trading in deCODE Stock
deCODE shares will continue to trade as usual pending Nasdaq listing review
REYKJAVIK, Iceland, April 28 /PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ:DCGN) announced that it has this evening received a letter from the Nasdaq Listing and Hearing Review Council stating that the Council has called for review the April... More...>> |
| 04/23/2009 | 7:00AM | PRNUS | deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
REYKJAVIK, Iceland, and ALAMEDA, California, April 23
/PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ:DCGN) and Celera Corporation (NASDAQ:CRA) today announced the signing of agreements under which deCODE has granted Celera non-exclusive worldwide licenses to deCODE's genetic markers for increased risk of major cardiovascular... More...>> |
| 04/15/2009 | 7:30AM | PRNUS | deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes
REYKJAVIK, Iceland, April 15 /PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ:DCGN) today announced that in order to provide more time for the execution of strategic alternatives currently under consideration, it has elected to utilize a 30-day grace period for the scheduled April 15 interest payment on its outstanding... More...>> |
| 03/31/2009 | 4:55PM | PRNUS | deCODE genetics Announces Full-year 2008 Financial Results
REYKJAVIK, Iceland, March 31 /PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ:DCGN) today announced its consolidated financial results for the quarter and year ended December 31, 2008. A conference call to discuss the year's results and recent developments in the company's business will be webcast live tomorrow, Wednesday... More...>> |
| 03/26/2009 | 8:49AM | PRNUS | deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2008 Financial Results
REYKJAVIK, Iceland, March 26 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (NASDAQ:DCGN) today announced that it will report its full-year 2008 financial results in a press release to be issued on Tuesday, March 31, after the close of the market in New York. The company will host a live webcast of its conference call... More...>> |
| 02/19/2009 | 9:29AM | PRNUS | deCODE Receives California Clinical Laboratory License
Californians can now Enjoy the Benefits of deCODE's Market-Leading DNA-Based Disease Risk Assessment Tests and Pioneering deCODEme(TM) Genome Scans
REYKJAVIK, February 19 /PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ:DCGN) today announced that it has received a clinical laboratory license from the State of California... More...>> |
| 02/09/2009 | 8:00AM | PRNUS | Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack
Genetic Variants Influencing White Blood Cell Counts are Linked to Increased Risk of Heart Attack and Asthma; Variants are Being Integrated Into deCODEme(TM)
REYKJAVIK, Iceland, February 9 /PRNewswire-FirstCall/ -- In a paper published today, scientists at deCODE genetics (NASDAQ:DCGN) and academic colleagues from four... More...>> |
| 02/06/2009 | 3:47PM | PRNUS | deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention
-- The Two Risk Variants are Being Integrated Into the deCODEme(TM) Personal Genome Analysis Service and the new deCODEme Cancer(TM) Scan
REYKJAVIK, Iceland, Feb. 6 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (NASDAQ:DCGN) today present the discovery of two single letter variations in the sequence of the... More...>> |